Glenmark Pharmaceuticals opened lower at ₹2,278.00, compared with its previous close of ₹2,283.00. During today's session, the stock has traded between ₹2,253.00 and ₹2,289.30, with an average traded price of ₹2,266.13. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 5 years ago in Glenmark Pharmaceuticals is now worth
₹ 43,042.00
giving a profit of
₹ 33,042.00 (330.42%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-17.70 (-0.78%)
Day High
₹2,289.30
Day Low
₹2,253.00
Day Open
₹2,278.00
Prev Close
₹2,283.00
Volume
2,59,977
Value Traded
₹58.91 Cr
1W Return
-1.29%
1M Return
-6.36%
3M Return
-0.77%
6M Return
4.72%
1Y Return
16.81%
Market Cap (₹ Cr.)
63,932
PE Ratio
35.80
PB Ratio
6.13
Dividend Yield
0.22%
ROE
12.96%
ROCE
16.21%
Book Value (₹)
372.47
Face Value (₹)
1.00
EPS (TTM)
17.11
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-1.29%
6 Week
-
1 Month
-6.36%
3 Month
-0.77%
9 Month
12.28%
Glenmark launches Adapalene Gel pump packs in US to tap $45.8m market
Glenmark Therapeutics Inc. USA launched Adapalene Gel USP 0.1% in pump packs on October 6, 2026. The launch targets a $45.8 million annual market segment in the United States. Product serves as therapeutic equivalent to Differin® Gel active ingredient.
7 days agoGlenmark Pharmaceuticals closes trading window ahead of Q2FY27 results
Glenmark Pharmaceuticals closed its trading window on October 1, 2026. The ban applies until 48 hours after Q2FY27 results are declared. Restrictions cover Directors, KMPs, and identified employees under SEBI regulations.
15 days agoGlenmark Pharmaceuticals shares worth ₹37.28 crore change hands on NSE
Approximately 1,50,735 Glenmark Pharmaceuticals shares were flagged in a large-trade signal on the NSE. The shares changed hands at ₹2,473.00 per share, with a combined value of ₹37.28 crore. This is a real-time trade-scanning signal and not a confirmed exchange-reported event. Official exchange disclosures for such activity are published only after market close.
20 days agoGlenmark Pharmaceuticals receives EIR from U.S. FDA for Goa facility
Glenmark Pharmaceuticals received an Establishment Inspection Report (EIR) from the U.S. FDA for its Goa manufacturing facility. The EIR was issued with a Voluntary Action Indicated (VAI) status. VAI status indicates no significant objectionable conditions were observed during the U.S. FDA inspection.
20 days agoGlenmark Pharmaceuticals to host analyst meet in Mumbai on Sep 29
Glenmark Pharmaceuticals to host analysts on September 29, 2026. Meeting held as part of PL Capital Emerging Titans 2026 Conference. Sessions will be physical in Mumbai with group and one-on-one formats. No unpublished price-sensitive information to be shared.
22 days agoGlenmark Pharmaceuticals approves ₹2.50 dividend, FY26 financials at AGM
Shareholders approved FY26 standalone and consolidated financial statements. Final dividend of ₹2.50 per equity share declared for FY26. Mrs. Blanche Saldanha reappointed as Non-Executive Director. Cost auditor remuneration ratified for FY27. All resolutions passed with majority support exceeding 95%.
1mo ago| Contract | Days to Expiry | LTP | Change | Change % | Volume | OI | OI Chg % |
|---|---|---|---|---|---|---|---|
| GLENMARK OCT FUT | 15 | 2,275.00 | -1.60 | -0.07 | 4,83,750 | 1,11,02,250 | 0.32 |
| GLENMARK NOV FUT | 42 | 2,294.80 | 7.50 | 0.33 | 9,750 | 55,875 | 5.67 |
| GLENMARK DEC FUT | 78 | 2,322.00 | 0.00 | 0.00 | 0 | 750 | 0.00 |
| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% | |
| ₹351.00 | +1.34% | ₹57,202.26 | 134.86 | -0.69% |
An investment of ₹10,000 made 5 years ago in Glenmark Pharmaceuticals is now worth
₹ 43,042.00
giving a profit of
₹ 33,042.00 (330.42%)
Note: Past profits do not guarantee future returns.
